Abbott India Q4 net dips 29 per cent to Rs 42 crore
New Delhi: Pharma firm Abbott India on Friday reported a 28.69 per cent plunge in standalone net profit to Rs 42.06 crore for the fourth quarter ended March 31, 2017.
The company had posted a net profit of Rs 58.99 crore for the corresponding period of the previous fiscal, Abbott India said in a filing to BSE.
Total income for the quarter under consideration, however, rose to Rs 730.87 crore as against Rs 702.39 crore for the same period a year ago. For the fiscal ended March this year the net profit stood at Rs 276.65 crore, compared to Rs 255.25 crore a year ago.
Total income of the company for the fiscal year ended March 2017 was Rs 2,996.33 crore as against Rs 2,696.23 crore in the previous fiscal year.
In a separate filing, the company said its board has recommended a final dividend of Rs 40 per equity share.
Shares of Abbott India closed at Rs 4,194.95 per scrip on BSE, down 0.24 per cent from its previous close.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd